Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden; Global Health Institute, University of Antwerp, Antwerp, Belgium.
Cell Host Microbe. 2024 Aug 14;32(8):1235-1247. doi: 10.1016/j.chom.2024.07.008.
The gut microbiota has been recognized as an important determinant in the initiation and progression of colorectal cancer (CRC), with recent studies shining light on the molecular mechanisms that may contribute to the interactions between microbes and the CRC microenvironment. Despite the increasing wealth of associations being established in the field, proving causality remains challenging. Obstacles include the high variability of the microbiome and its context, both across individuals and across time. Additionally, there is a lack of large and representative cohort studies with long-term follow-up and/or appropriate sampling methods for studying the mucosal microbiome. Finally, most studies focus on CRC, whereas interactions between host and bacteria in early events in carcinogenesis remain elusive, reinforced by the heterogeneity of CRC development. Here, we discuss these current most prominent obstacles, the recent developments, and research needs.
肠道微生物群已被认为是引发和促进结直肠癌(CRC)的重要决定因素,最近的研究揭示了可能有助于微生物与 CRC 微环境相互作用的分子机制。尽管该领域已经确定了越来越多的关联,但证明因果关系仍然具有挑战性。障碍包括微生物组及其环境的高度可变性,无论是个体之间还是时间之间。此外,缺乏具有长期随访和/或适当取样方法的大型代表性队列研究来研究粘膜微生物组。最后,大多数研究都集中在 CRC 上,而宿主和细菌之间在癌变早期事件中的相互作用仍然难以捉摸,CRC 发展的异质性进一步加剧了这种情况。在这里,我们讨论了这些当前最突出的障碍、最新进展和研究需求。